Research Article
Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy
Table 6
Results of molecular docking.
| Core component | Target | PDB ID | Binding energy (kcal/mol) |
| | VEGFA | 4QAF | −5.8 | IL6 | 1ALU | −5.4 | Quercetin | TNF | 6OP0 | −10 | AKT1 | 4GV1 | −7.9 | TP53 | 5O1E | −8.2 | VEGFA | 4QAF | −9.4 | IL6 | 1ALU | −5.5 | Formononetin | TNF | 6OP0 | −9.2 | AKT1 | 4GV1 | −8.4 | TP53 | 5O1E | −7.6 | VEGFA | 4QAF | −6.1 | IL6 | 1ALU | −5.7 | Kaempferol | TNF | 6OP0 | −10.1 | AKT1 | 4GV1 | −7.8 | TP53 | 5O1E | −7.0 | VEGFA | 4QAF | −8.1 | IL6 | 1ALU | −5.2 | Isorhamnetin | TNF | 6OP0 | −8.2 | AKT1 | 4GV1 | −8.2 | TP53 | 5O1E | −8.0 | VEGFA | 4QAF | −7.7 | IL6 | 1ALU | −5.1 | Beta-Sitosterol | TNF | 6OP0 | −9.7 | AKT1 | 4GV1 | −9.3 | TP53 | 5O1E | −6.1 |
|
|